Paul Weller

1.4k total citations
19 papers, 867 citations indexed

About

Paul Weller is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Paul Weller has authored 19 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Paul Weller's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (3 papers). Paul Weller is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (3 papers). Paul Weller collaborates with scholars based in United States and Switzerland. Paul Weller's co-authors include Lawrence J. Marnett, Mario Monshouwer, Robert P. Hanzlik, Xingrong Liu, Helen Yeo, Philip Worboys, Gary Peltz, Jonathan Usuka, Steven L. Shafer and Ashis K. Basu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Paul Weller

19 papers receiving 850 citations

Peers

Paul Weller

PHARM

ONCOL

P.M. Woollard United Kingdom

Alan P. Breau United States

Grant L. Schoenhard United States

Joseph A. Zirrolli United States

L.J. Marnett United States

Ranjinder S. Sidhu Canada

Carmela Gnerre Switzerland

Matthias Lehr Germany

Lawrence J. Marnett United States

Norman Huebert United States

P.M. Woollard United Kingdom

Paul Weller

403 ×1.3

179 ×0.8

PHARM

88 ×0.4

PHARM

276 ×1.7

114 ×1.0

ONCOL

Citations per year, relative to Paul Weller Paul Weller (= 1×) peers P.M. Woollard

Countries citing papers authored by Paul Weller

Since Specialization

Citations

This map shows the geographic impact of Paul Weller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Weller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Weller more than expected).

Fields of papers citing papers by Paul Weller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Weller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Weller. The network helps show where Paul Weller may publish in the future.

Co-authorship network of co-authors of Paul Weller

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Weller. A scholar is included among the top collaborators of Paul Weller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Weller. Paul Weller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhang, Xiang, Hong-Hsing Liu, Paul Weller, et al.. (2010). In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. The Pharmacogenomics Journal. 11(1). 15–24. 71 indexed citations

Padilla, Fernando, Surya Sankuratri, Changhua Ji, et al.. (2010). Synthesis, SAR and evaluation of [1,4′]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(11). 3219–3222. 8 indexed citations

Trejo‐Martin, Alejandra, Eun Kyung Lee, Surya Sankuratri, et al.. (2009). Spiropiperidine CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5401–5406. 17 indexed citations

Liu, Xingrong, et al.. (2008). Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid. Drug Metabolism and Disposition. 37(4). 787–793. 141 indexed citations

Guo, Yingying, Peng Lü, Xun Zhang, et al.. (2007). In silico and in vitro pharmacogenetic analysis in mice. Proceedings of the National Academy of Sciences. 104(45). 17735–17740. 43 indexed citations

Guo, Yingying, Paul Weller, Paul Cheung, et al.. (2006). In silico pharmacogenetics of warfarin metabolism. Nature Biotechnology. 24(5). 531–536. 53 indexed citations

Guo, Yingying, Steven L. Shafer, Paul Weller, Jonathan Usuka, & Gary Peltz. (2005). Pharmacogenomics and Drug Development. Pharmacogenomics. 6(8). 857–864. 19 indexed citations

Campbell, Jeffrey A., Chris A. Broka, Michelle F. Browner, et al.. (2004). Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(18). 4741–4745. 52 indexed citations

Terry, Alvin V., Jerry J. Buccafusco, William James Jackson, et al.. (1998). Enhanced delayed matching performance in younger and older macaques administered the 5-HT 4 receptor agonist, RS 17017. Psychopharmacology. 135(4). 407–415. 61 indexed citations

10.

Weller, Paul & Robert P. Hanzlik. (1991). Isolation of S-(bromophenyl)cysteine isomers from liver proteins of bromobenzene-treated rats. Chemical Research in Toxicology. 4(1). 17–20. 13 indexed citations

11.

Hanzlik, Robert P., et al.. (1990). Synthesis of mercapturic acid derivatives of putative toxic metabolites of bromobenzene. The Journal of Organic Chemistry. 55(9). 2736–2742. 30 indexed citations

12.

Weller, Paul & Robert P. Hanzlik. (1988). Synthesis of substituted bromobenzene derivatives via bromoanilines. A moderately selective ortho‐bromination of [¹⁴c]‐aniline. Journal of Labelled Compounds and Radiopharmaceuticals. 25(9). 991–998. 5 indexed citations

13.

Narasimhan, Sangeetha, et al.. (1988). Microsomal metabolism and covalent binding of [³H/¹⁴C]-bromobenzene. Evidence for quinones as reactive metabolites. Xenobiotica. 18(5). 491–499. 32 indexed citations

14.

Weller, Paul, et al.. (1988). In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.. Drug Metabolism and Disposition. 16(2). 232–237. 9 indexed citations

15.

Weller, Paul, et al.. (1987). Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities.. Journal of Biological Chemistry. 262(13). 6266–6279. 194 indexed citations

16.

Marnett, Lawrence J., et al.. (1986). Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxadiazabicyclononene residues in the base-pairing region. Journal of the American Chemical Society. 108(6). 1348–1350. 58 indexed citations

17.

Weller, Paul, et al.. (1985). Enzymatic reduction of 5-phenyl-4-pentenyl-hydroperoxide: Detection of peroxidases and identification of peroxidase reducing substrates. Archives of Biochemistry and Biophysics. 243(2). 633–643. 33 indexed citations

18.

Weller, Paul, et al.. (1985). Effects of prostaglandins possessing an alpha,beta-unsaturated carbonyl on tumor growth and differentiation.. PubMed. 15. 411–3. 1 indexed citations

19.

Panthananickal, Augustine, Paul Weller, & Lawrence J. Marnett. (1983). Stereoselectivity of the epoxidation of 7,8-dihydrobenzo[a]pyrene by prostaglandin H synthase and cytochrome P-450 determined by the identification of polyguanylic acid adducts.. Journal of Biological Chemistry. 258(7). 4411–4418. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact